← Research Blog

KLOW Stack: BPC-157 + TB-500 + GHK-Cu + KPV Research Guide (2026)

The KLOW Stack is a curated research blend combining three extensively studied peptides: GHK-Cu (copper tripeptide), KPV (α-MSH C-terminal tripeptide), and BPC-157 (Body Protection Compound). Each compound has an independent research record spanning decades — together, they represent a convergence of skin biology, anti-inflammatory signaling, and tissue repair mechanisms that researchers are increasingly investigating in multi-compound studies.

This guide covers the published science behind each component, the mechanistic rationale for combining them, and what researchers need to know about sourcing and handling this blend.

What Is the KLOW Stack?

The KLOW Stack is a lyophilized research blend containing GHK-Cu, KPV, and BPC-157 in a single preparation. It is sold exclusively for in vitro laboratory research purposes. The name KLOW references the compounds' overlapping research areas — collagen remodeling, inflammation, tissue healing — and their documented interactions with extracellular matrix biology and the melanocortin system.

GHK-Cu: The Foundation of KLOW

Glycyl-L-histidyl-L-lysine copper(II) (GHK-Cu) is arguably the most documented component of the KLOW stack. First identified in 1973 by Dr. Loren Pickart, GHK-Cu is a naturally occurring tripeptide found in human plasma, saliva, and urine that chelates copper ions. Its concentration declines significantly with age — from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 — making it a subject of considerable longevity and anti-aging research.

Collagen & Extracellular Matrix Research

• Collagen synthesis: GHK-Cu stimulates production of type I and type III collagen in dermal fibroblast cultures, with effects confirmed across multiple independent studies (Pickart et al., 2012; Gorouhi & Maibach, 2009)
• Elastin and proteoglycans: Research documents upregulation of elastin synthesis and glycosaminoglycan deposition in 3D skin culture models
• MMP modulation: GHK-Cu both stimulates collagen-degrading matrix metalloproteinases (for remodeling) and their tissue inhibitors (TIMPs), suggesting a regulatory rather than simply anabolic role in ECM biology

Gene Expression Research

One of the most striking findings in GHK-Cu research is its broad effect on gene expression. A 2012 microarray analysis (Pickart et al.) found that GHK-Cu modulated the expression of over 4,000 human genes, including upregulation of antioxidant defense genes (SOD, catalase), DNA repair systems, anti-inflammatory pathways, and genes associated with youthful tissue phenotypes. In aged tissue models, GHK-Cu treatment partially reversed the gene expression profile toward younger patterns.

Wound Healing & Skin Research

• Studies show GHK-Cu significantly accelerates wound contraction rates in animal models
• Research documents improved skin barrier function and reduced transepidermal water loss in skin culture models
• Antioxidant effects: GHK-Cu increases superoxide dismutase activity and reduces oxidative damage markers in cell culture studies

KPV: The Anti-Inflammatory Core

Lys-Pro-Val (KPV) is the C-terminal tripeptide of alpha-melanocyte stimulating hormone (α-MSH), and it retains many of the parent molecule's anti-inflammatory properties in a much smaller, more stable molecule. KPV has been studied extensively for its interactions with melanocortin receptors — particularly MC1R and MC3R — and its downstream effects on inflammatory signaling cascades.

NF-κB Inhibition Research

• Core mechanism: KPV inhibits nuclear translocation of NF-κB, a master transcription factor regulating hundreds of pro-inflammatory gene targets. This has been demonstrated in multiple cell line studies (Catania et al., 2004)
• Cytokine modulation: Research shows KPV reduces production of TNF-α, IL-6, IL-1β, and other pro-inflammatory cytokines in stimulated macrophage and keratinocyte cultures
• MAPK pathway: Studies document effects on MAP kinase signaling cascades involved in inflammation and cellular stress responses

Skin & Gut Inflammation Research

• KPV demonstrates anti-inflammatory effects in skin cell culture models, including keratinocytes stimulated with LPS and UV radiation
• Intestinal research: KPV penetrates gut epithelial cells via the PepT1 transporter, making it of particular interest for gastrointestinal inflammation models (Dalmasso et al., 2008)
• Wound healing: Studies show KPV accelerates re-epithelialization in scratch-wound assays, potentially through combined anti-inflammatory and proliferative effects

BPC-157: The Tissue Repair Component

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid pentadecapeptide derived from a sequence in human gastric juice. With over 100 published preclinical studies, it is one of the most researched peptides in regenerative biology. See our full BPC-157 research guide for an in-depth review.

Key BPC-157 Research Areas

• Angiogenesis: BPC-157 upregulates VEGF expression and promotes new blood vessel formation — a critical prerequisite for tissue repair in ischemic models
• Tendon and connective tissue: Multiple studies document accelerated healing in transected tendon and ligament models, with histological confirmation of improved collagen organization (Staresinic et al., 2003)
• Gastrointestinal biology: Extensive research on gut barrier protection, anti-ulcer effects, and inflammatory bowel model responses
• NO system interaction: BPC-157 modulates nitric oxide synthase activity, contributing to its vascular and anti-inflammatory research profile

Why Combine These Three? — Mechanistic Rationale

The KLOW stack is designed around complementary, non-redundant mechanisms across the tissue repair cascade:

• GHK-Cu targets the extracellular matrix layer — stimulating collagen synthesis, remodeling scaffolding, and activating longevity-associated gene programs
• KPV addresses the inflammatory microenvironment — inhibiting NF-κB and dampening cytokine production that would otherwise impede repair processes
• BPC-157 drives vascularization and tissue architecture — promoting angiogenesis and structural healing at the level of tendons, muscle, and epithelium

Together, the three compounds address inflammation (KPV), structural repair (BPC-157), and ECM remodeling/gene regulation (GHK-Cu) — distinct biological phases that researchers studying complex tissue biology may want to investigate simultaneously.

Research Use Cases

• Skin biology and wound healing mechanism studies
• Extracellular matrix remodeling research in 3D culture models
• Multi-compound anti-inflammatory signaling studies
• Angiogenesis and vascularization research
• NF-κB pathway and melanocortin receptor biology
• Longevity and anti-aging pathway investigations in vitro

Individual Components — Also Available Separately

Researchers who want to run single-compound controls alongside KLOW stack experiments can source each component individually:

• GHK-Cu (copper peptide) — individual vial, 50mg and 100mg sizes
• KPV — individual vial, 10mg
• BPC-157 — individual vial, 10mg and 20mg sizes

Storage & Handling

• Long-term storage: –20°C, protected from light and moisture
• Short-term (after reconstitution): 4°C, use within 28–30 days
• Reconstitution: Use bacteriostatic water; gentle swirling only — do not vortex
• Freeze-thaw cycles: Minimize; aliquot before freezing if multiple uses are planned
• Lot-specific COA included with every OPSEK Labs order

Purity Standards

Each component of the KLOW Stack is independently verified to ≥99% purity by third-party HPLC analysis before blending, with mass spectrometry confirmation of molecular identity. OPSEK Labs publishes lot-specific Certificates of Analysis for every batch — not generic template documents.